Yuichi Saito
Chiba University
67 Papers
149 Citations
Yuichi Saito is an academic researcher from Chiba University. The author has contributed to research in topics: Medicine & Percutaneous coronary intervention. The author has an hindex of 9, co-authored 67 publications. Previous affiliations of Yuichi Saito include Yale University.
Chat about Author
Papers
Triple therapy: A review of antithrombotic treatment for patients with atrial fibrillation undergoing percutaneous coronary intervention
TL;DR: There are a number of unresolved issues regarding the antithrombotic treatment for patients with AF undergoing PCI such as risk prediction models and the best combination of OAC with antiplatelet agents, and prospective trials are ongoing.
15
Prevalence of Achilles tendon xanthoma and familial hypercholesterolemia in patients with coronary artery disease undergoing percutaneous coronary intervention.
Hideki Kitahara,Naoto Mori,Yuichi Saito,Takashi Nakayama,Yoshihide Fujimoto,Yoshio Kobayashi +5 more
TL;DR: Investigation of the prevalence of Achilles tendon xanthoma (ATX) and heterozygous FH in patients with stable CAD and ACS undergoing percutaneous coronary intervention (PCI) found a certain number of ATX and heterogeneous FH were also detected in stable CAD patients.
11
Preoperative Assessment of Endothelial Function for Prediction of Adverse Events After Cardiovascular Surgery.
TL;DR: Preoperative endothelial dysfunction assessed by RHI was associated with postoperative AEs in patients with cardiovascular surgery, and the number of surgical procedures and RHI ≤1.64 as significant predictors of AEs were shown.
10
Relation of Plasma Xanthine Oxidoreductase Activity to Coronary Lipid Core Plaques Assessed by Near-Infrared Spectroscopy Intravascular Ultrasound in Patients with Stable Coronary Artery Disease
Naoto Mori,Yuichi Saito,Kan Saito,Takaaki Matsuoka,Kazuya Tateishi,Tadayuki Kadohira,Hideki Kitahara,Yoshihide Fujimoto,Yoshio Kobayashi +8 more
TL;DR: Elevated XOR activity was associated with coronary lipid-rich plaque in a nontarget vessel in patients with stable coronary artery disease and was demonstrated to have longer lesion length, smaller minimum lumen diameter, and higher percentage of diameter stenosis in the high XOR group among the 3 groups.
10